Investors & Media

Press Releases

Press Releases

Press Releases

  • February 27, 2020

    Anokion Announces Initiation of Patient Dosing in Phase 1 Clinical Trial of KAN-101 in Celiac Disease

    Read More
  • February 24, 2020

    Anokion to Present at the Cowen 40th Annual Healthcare Conference

    Read More
  • February 19, 2020

    Anokion to Present at the 3rd Antigen Specific Immune Tolerance Summit

    Read More
  • January 21, 2020

    Anokion Announces FDA Clearance of IND Application for its Lead Program in Celiac Disease

    Read More
  • January 08, 2020

    Anokion to Participate in Autoimmune and Inflammatory Disease Panel at 2020 Biotech Showcase

    Read More